scispace - formally typeset
Q

Qing Ma

Researcher at Cincinnati Children's Hospital Medical Center

Publications -  63
Citations -  11880

Qing Ma is an academic researcher from Cincinnati Children's Hospital Medical Center. The author has contributed to research in topics: Acute kidney injury & Kidney. The author has an hindex of 32, co-authored 57 publications receiving 10988 citations. Previous affiliations of Qing Ma include University of Cincinnati Academic Health Center & University of Cincinnati.

Papers
More filters
Journal ArticleDOI

Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery

TL;DR: Univariate analysis showed a significant correlation between acute renal injury and the following: urine and serum concentrations of NGAL at 2 h, and cardiopulmonary bypass time.
Journal ArticleDOI

Identification of Neutrophil Gelatinase-Associated Lipocalin as a Novel Early Urinary Biomarker for Ischemic Renal Injury

TL;DR: The results indicate that NGAL may represent an early, sensitive, noninvasive urinary biomarker for ischemic and nephrotoxic renal injury.
Journal ArticleDOI

Urine NGAL Predicts Severity of Acute Kidney Injury After Cardiac Surgery: A Prospective Study

TL;DR: Urine NGAL is an early predictive biomarker of AKI severity after CPB and accurate measurements of urine NGAL are obtained using the ARCHITECT platform.
Journal ArticleDOI

Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery.

TL;DR: Interleukin-18 is an early, predictive biomarker of AKI after CPB, and that NGAL and IL-18 are increased in tandem afterCPB, suggesting the combination of these two biomarkers may allow for the reliable early diagnosis and prognosis ofAKI at all times after CPBs.
Journal ArticleDOI

Neutrophil Gelatinase-Associated Lipocalin: A Novel Early Urinary Biomarker for Cisplatin Nephrotoxicity

TL;DR: This study has explored the expression and urinary excretion of neutrophil gelatinase-associated lipocalin (NGAL) in a mouse model of cisplatin-induced nephrotoxic injury and indicates that NGAL represents an early and quantitative urinary biomarker for cisPlatin neph rotoxicity.